The Michael J. Berendt Sells 1,000 Shares of Waters Co. (WAT) Stock

The Michael J. Berendt Sells 1,000 Shares of Waters Co. (WAT) Stock

Waters Co. (NYSE:WAT) opened at 183.96 on Monday. The stock’s 50 day moving average price is $172.14 and its 200-day moving average price is $152.54. Waters Co. has a one year low of $131.35 and a one year high of $184.57. The company has a market capitalization of $14.72 billion, a P/E ratio of 27.97 and a beta of 0.83.

Waters Co. (NYSE:WAT) Director Michael J. Berendt sold 1,000 shares of Waters stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $174.01, for a total value of $174,010.00. Following the sale, the director now owns 23,349 shares in the company, valued at $4,062,959.49. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, April 25th. The medical instruments supplier reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.13. Waters had a return on equity of 24.47% and a net margin of 24.06%. The company had revenue of $497.97 million for the quarter, compared to analysts’ expectations of $489.37 million. During the same period in the prior year, the firm earned $1.26 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year. Equities analysts forecast that Waters Co. will post $7.32 EPS for the current year.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, April 25th. The medical instruments supplier reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.13. Waters had a return on equity of 24.47% and a net margin of 24.06%. The company had revenue of $497.97 million for the quarter, compared to analysts’ expectations of $489.37 million. During the same period in the prior year, the firm earned $1.26 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year. Equities analysts forecast that Waters Co. will post $7.32 EPS for the current year. WAT has been the subject of several recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $170.00 price objective on shares of Waters in a report on Friday, March 3rd. Jefferies Group LLC boosted their target price on Waters from $147.00 to $150.00 and gave the stock a “hold” rating in a research report on Friday, March 3rd. Evercore ISI downgraded Waters from a “hold” rating to an “underperform” rating in a research report on Friday, March 3rd. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $178.00 price objective for the company in a research report on Monday, April 24th. Finally, Cowen and Company boosted their price objective on Waters from $160.00 to $175.00 and gave the company a “market perform” rating in a research report on Wednesday, April 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $168.91.

Several hedge funds have recently made changes to their positions in the stock. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of Waters by 2.8% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 13,634 shares of the medical instruments supplier’s stock valued at $2,161,000 after buying an additional 368 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of Waters by 1.4% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 231,509 shares of the medical instruments supplier’s stock valued at $36,692,000 after buying an additional 3,249 shares during the last quarter. Rothschild Asset Management Inc. boosted its stake in shares of Waters by 15.9% in the third quarter. Rothschild Asset Management Inc. now owns 3,179 shares of the medical instruments supplier’s stock valued at $504,000 after buying an additional 436 shares during the last quarter. World Asset Management Inc boosted its stake in shares of Waters by 1.7% in the third quarter. World Asset Management Inc now owns 8,081 shares of the medical instruments supplier’s stock valued at $1,281,000 after buying an additional 138 shares during the last quarter. Finally, BRC Investment Management LLC bought a new stake in shares of Waters during the third quarter valued at about $715,000. Institutional investors and hedge funds own 92.53% of the company’s stock. About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “WAT”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment